Cargando…
Addition of Gallic Acid Overcomes Resistance to Cisplatin in Ovarian Cancer Cell Lines
OBJECTIVE: Ovarian cancer is one of the leading causes of cancer-related mortality in women, and is often associated with drug resistance. Therefore, finding effective drugs, including naturally derived compounds, is urgently needed. Herein, we aimed to test the anti-cancer potential of gallic acid...
Autores principales: | Al Balushi, Najwa, Hassan, Syed Imran, Abdullah, Nada, Al Dhahli, Buthaina, Al Bahlani, Shadia, Ikhlas, Ikhlas, Tsang, Benjamin K, Dobretsov, Sergey, Tamimi, Yahya, Burney, Ikram A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9741893/ https://www.ncbi.nlm.nih.gov/pubmed/36037120 http://dx.doi.org/10.31557/APJCP.2022.23.8.2661 |
Ejemplares similares
-
Hymenialdisine is Cytotoxic Against Cisplatin-Sensitive but Not Against Cisplatin-Resistant Cell Lines
por: Abdullah, Nada, et al.
Publicado: (2021) -
Malformin-A1 (MA1) Sensitizes Chemoresistant Ovarian Cancer Cells to Cisplatin-Induced Apoptosis
por: Abdullah, Nada, et al.
Publicado: (2021) -
Boswellic acid sensitizes gastric cancer cells to Cisplatin-induced apoptosis via p53-mediated pathway
por: Al-Bahlani, Shadia, et al.
Publicado: (2020) -
Platinum-Based Drugs Differentially Affect the Ultrastructure of Breast Cancer Cell Types
por: Al-Bahlani, Shadia, et al.
Publicado: (2017) -
Gallic acid
por: Zhao, Jianping, et al.
Publicado: (2011)